Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy.

Bioimpacts · 2023 · PMC10509739 · PMID 37736339

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

approached the level of significanceP = 0.057so close (0.05 < p ≤ 0.1)

The ratio of isolated WT1-reactive T cells to the starting CD3 + T cell subset of PBMCs was higher in patients with Wilms tumor than in healthy donors, although the difference only approached the level of significance (mean (SD), 2 (0.4) % vs. 1.4 (0.5) %; P = 0.057).

also in 10 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.